Cancer-associated thrombosis
You must score at least 70% in this module to pass. Ensure you have read ‘Cancer-associated thrombosis’ before attempting to complete the module.
This module can be taken up to three times. Once you have passed, you can view the correct answers and download a certificate as a record of your learning.
Additional CPD modules are available in the ‘My CPD’ section of your account.
Quiz Summary
0 of 15 Questions completed
Questions:
Information
You have already completed the quiz before. Hence you can not start it again.
Quiz is loading…
You must sign in or sign up to start the quiz.
You must first complete the following:
Results
Results
0 of 15 Questions answered correctly
Your time:
Time has elapsed
You have reached 0 of 0 point(s), (0)
Earned Point(s): 0 of 0, (0)
0 Essay(s) Pending (Possible Point(s): 0)
Categories
- Not categorized 0%
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- Current
- Review
- Answered
- Correct
- Incorrect
- Question 1 of 15
1. Question
The All Party Parliamentary Thrombosis Group (APPTG) 2016 reviewed the state of cancer-associated thrombosis in the UK. Which of the following is a correct statement made by APPTG?
CorrectIncorrect - Question 2 of 15
2. Question
The Virchow’s triad has formed the basis of our understanding of the pathogenesis of venous thromboembolism for some time. Virchow’s triad model proposed that factors that increase the risk of thrombosis may be broadly divided into three cancer-associated thrombosis categories. Which statement shows the three categories included in Virchow’s triad?
CorrectIncorrect - Question 3 of 15
3. Question
Risk factors for the development of cancer-associated thrombosis can be both general and specific to patients with cancer. Which statement is correct for common risk factors specific to patients with cancer?
CorrectIncorrect - Question 4 of 15
4. Question
In a meta-analysis, which cancer has the highest risk of cancer-associated thrombosis?
CorrectIncorrect - Question 5 of 15
5. Question
Cancer-associated thrombosis is an important cause of morbidity and mortality in patients with cancer. Which statement is correct?
CorrectIncorrect - Question 6 of 15
6. Question
Based on current guidelines, which statement is correct?
CorrectIncorrect - Question 7 of 15
7. Question
Treatment of cancer-associated thrombosis (lower extremity venous thrombosis/pulmonary embolism) is with anticoagulant therapies. Which anticoagulants are licensed for the treatment of cancer-associated thrombosis in the first six months?
CorrectIncorrect - Question 8 of 15
8. Question
National and international organisation have based their recommendations on the initial treatment of cancer-associated thrombosis (lower extremity venous thrombosis/pulmonary embolism) to use:
CorrectIncorrect - Question 9 of 15
9. Question
Regarding the risk of bleeding, which statement is correct?
CorrectIncorrect - Question 10 of 15
10. Question
Which one of the following statements regarding use of anticoagulation beyond six months in cancer-associated thrombosis is correct?
CorrectIncorrect - Question 11 of 15
11. Question
Which of the following is correct in relation to venous thromboembolism (VTE) extension/recurrence while on anticoagulation?
CorrectIncorrect - Question 12 of 15
12. Question
Which one of the following is correct in terms of the prevention of venous thromboembolism in patients with myeloma?
CorrectIncorrect - Question 13 of 15
13. Question
Which one of the following is correct in terms of the prevention of venous thromboembolism in ambulatory chemotherapy patients?
CorrectIncorrect - Question 14 of 15
14. Question
Which of the following is correct in terms of the prevention of venous thromboembolism in ambulatory patients who have surgery for cancer?
CorrectIncorrect - Question 15 of 15
15. Question
Which one of the following is correct in terms of the cancer-associated thrombosis patient’s journey?
CorrectIncorrect